SHINGRIX®: Clinical Trials

1 trial of SHINGRIX®, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow SHINGRIX®: new trials by email Literature Review of SHINGRIX® trials Research Report on SHINGRIX®

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Simultaneous RZV and aIIV4 Vaccination
FLUAD® Quadrivalent, Fluzone® High-Dose Quadrivalent, SHINGRIX® - Pain, Quality of Life
Phase 4CompletedDuke University2672021-09-212024-07-11

Conditions studied

Drug-Related Side Effects and Adverse Reactions (1)  ·  Influenza, Human (1)  ·  Injection Site Reaction (1)  ·  Pain (1)

Sponsors

Duke University (1)

Countries

United States (1)

Top investigators

Kenneth Schmader, MD (1)

Results publications

PMID 37781954, PMID 39446325